SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Aventus Network

Aventus Network ($AVT) is trending, with community members pointing to its strong chart setup, real-world partnerships, and integration with Polkadot, which they believe positions the token for a potential breakout. Discussions highlight the token's low market cap and potential for significant upside, with traders closely monitoring volume as a key indicator for price movement.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as the community rallies around the self-proclaimed "culture coin," emphasizing its longevity and cultural significance. Many community members are sharing links to the project's website and DEX Screener, while also inviting others to join the Weedcoin community. The coin is being touted as "like Bitcoin but way higher."

HashPack is the leading retail wallet on Hedera Hashgraph with a fantastic user experience for defi, NFTs and dApps. The wallet is non-custodial, audited and features free email account creation as well as seed phrase based account creation. HashPack is integrated with every major dApp in the Hedera Hashgraph ecosystem and is deeply involved in the retail and developer communities.

HashPack

HashPack ($PACK) is trending as the community discusses its utility within the Hedera ecosystem, including staking, governance, and rewards. Recent updates, like the token buyback program and enhanced in-wallet functionality (Coinbase fiat onramp, improved DeFi swaps), are generating buzz. Speculation around a major app overhaul (dubbed "Project X") and potential cross-chain interoperability are also key talking points.

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI is trending amid community excitement, with potential CoinMarketCap (CMC) listing buzz circulating. The community highlights the token's strong holders and uplifting narrative, emphasizing its position within the Solana and PUMP ecosystems. Discussions also focus on WAGMI's potential for long-term growth.

CEL-SCI Corp. is a clinical-stage biotechnology company, which engages in the research, development, and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS). Multikine is an investigational immunotherapy for the potential treatment of head and neck cancers. LEAPS is categorized into LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza for hospitalized patients and CEL-2000 and CEL-4000, which are vaccine candidates for the treatment of rheumatoid arthritis. The company was founded by Maximilian de Clara on March 22, 1983 and is headquartered in Vienna, VA.

Cel-Sci Corp.

Cel-Sci ($CVM) is trending due to the filing of a Breakthrough Medicine Designation application in Saudi Arabia for its Multikine immunotherapy, potentially leading to patient access and reimbursement within 60 days if approved. The community is focused on the implications of this filing with the SFDA and a potential partnership with Dallah Pharma for commercialization in the MENA region, aligning with Saudi's Vision 2030 goals in healthcare. Discussions also involve the possibility of accelerated FDA approval and the company's long-term potential in the biotech sector.

CATULU | THE THREADED FAMILIAR  Catulu is like Tamagotchi for the Twitter age — except your pet lives on the timeline, and the more you play, the more everyone sees it.  Platform & Core Mechanics Platform: Twitter + Web3 (Solana) Core Loop: Tweeting = Feeding, Cleansing, Training Tokens: $CATULU (native currency of the ecosystem)   Level up your characters to unlock more avatar images , get into top ranks on leaderboard and earn LP rewards.

CATULU

CATULU is trending as community members highlight its availability on Phantom Wallet, making it easily accessible for trading. Some users are pointing to bullish chart patterns and anticipating further upward movement, while others suggest potential listings on larger exchanges. The overall sentiment is very positive, with many encouraging others to buy.

Hydrex is the MetaDEX & Liquidity Infrastructure purpose-built for Base. By combining automated strategies, liquid-backed tokenomics, and Base's powerful distribution channels, Hydrex removes the barriers to yield. It's designed as a coordination system where weekly community governance directs HYDX emissions & protocol revenue. Value flows to where liquidity and volume are most productive, based on protocol alignment.

Hydrex

Hydrex ($HYDX) is trending as a potential competitor to $AERO, with community members highlighting its recent launch on Base as a DUNA and its locked tokenomics. The project's low market cap and social media activity are fueling speculation about potential gains, with some anticipating a Coinbase listing.

Aptos is a new, independent high-performance PoS Layer 1 project focused on delivering the safest and most scalable Layer 1 blockchain in the world. The Aptos blockchain leverages the Move programming language and the Move VM for application development, which are created and optimized for blockchain use cases.The team is comprised of the original creators, researchers, designers, and builders of Diem, the blockchain that was first built to serve this purpose. Aptos raised $200m from a16z, Multicoin, Binance and others. Aptos launched Devnet in mid March, incentivized testnet in late May and targets Q3 for mainnet launch.

Aptos

Aptos is trending as community members discuss its potential, with some calling it the "new Solana". The launch of the Trump stablecoin, USD1, on the Aptos blockchain is generating excitement, with investors speculating about increased adoption and potential price appreciation. Partnerships with World Liberty Finance and integrating Aave V3 have also sparked interest.

Vicarious Surgical, Inc. a blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. It also designs surgical robotics. The company was founded by Adam Sachs, Sammy Khalifa, and Barry Greene on May 1, 2014 and is headquartered in Waltham, MA.

Vicarious Surgical Inc - Ordinary Shares - Class A

RBOT is trending as investors discuss the potential of its surgical robotics technology and recent Piper Sandler rating. Community members are weighing the company's cash runway against its long-term potential, with some anticipating a near-term capital raise or partnership. Despite concerns about dilution and clinical trial delays, some traders see a speculative buying opportunity due to the small float and backing from major investors.

ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray. The company was founded by Richard Lowenthal, Robert Bell, and Sarina Tanimoto on August 5, 2015 and is headquartered in San Diego, CA.

ARS Pharmaceuticals Inc

ARS Pharmaceuticals is trending as the community discusses the potential of Neffy, its needle-free epinephrine spray, especially after recent global approvals and positive reception. Some are noting the company's strong financial backing and patent protection, while others discuss potential competition. Discussions also involve potential short squeeze setups and revenue projections.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Analyst Favorites With Strong Buyback Activity: Rush Enterprises Ranks As a Top Pick

A study of analyst recommendations at the major brokerages shows that Rush Enterprises Inc. (RUSHA) is the #16 broker analyst pick among those stocks screened by The Online Investor for strong stock...

Rush Enterprises A Announces Executive Shuffles and Rewards

Rush Enterprises A (RUSHA) has issued an update. Rush Enterprises, Inc. has announced significant executive changes, with COO Michael J. McRoberts...

Rush Enterprises COO Michael McRoberts to step down later this year

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Rush Enterprises (RUSHB, $51.17) entered Uptrend as Momentum indicator ascends above 0 level on Mar 04, 2024

This indicator may be signaling RUSHB's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...

Rush Enterprises (RUSHB, $49.12) price moved above its 50-day Moving Average on February 23, 2024

This price move could indicate a change in the trend, and may be a buy signal for investors...

Ex-Dividend Reminder: Rush Enterprises, NextEra Energy and Laboratory Corporation of America Holdings

On 2/26/24, Rush Enterprises Inc. (RUSHA), NextEra Energy Inc (NEE), and Laboratory Corporation of America Holdings (LH) will all trade ex-dividend for their respective upcoming dividends...

Rush Enterprises (RUSHB, $49.73) entered Uptrend as Momentum indicator ascends above 0 level on Feb 14, 2024

Recap: Rush Enterprises Q4 Earnings

Are Robust Financials Driving The Recent Rally In Rush Enterprises, Inc.'s (NASDAQ:RUSH.A) Stock?

Most readers would already be aware that Rush Enterprises' (NASDAQ:RUSH.A) stock increased significantly by 25% over...

Rush Enterprises (RUSHA, $47.44) price may drop as it broke higher Bollinger Band on Feb 09, 2024

This price move could be a signal that RUSHA may fall back below the higher band and head toward the middle band. Traders may consider selling the stock, shorting the stock, or exploring put options...

Rush Enterprises, Inc. engages in the business of retailing commercial vehicles. It operates under the Truck and All Other segments. The Truck segment includes an operating network of commercial vehicle dealerships that provide an integrated one-stop source for the commercial vehicle needs of its customers, including retail sales of new and used commercial vehicles, aftermarket parts, service, and collision center facilities, and financial services, including the financing of new and used commercial vehicle purchases, insurance products, and truck leasing and rentals. The All Other segment focuses on the retail tire company, an insurance agency, and a guest ranch operation. The company was founded by W. Marvin Rush in 1965 and is headquartered in New Braunfels, TX.

Rush Enterprises Inc - Ordinary Shares - Class B

Will PepsiCo ($PEP) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

PepsiCo Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	$0.81	--	--	N/A
Q2 '25	$0.77	$0.90	16.88%	BEAT
Q1 '25	$0.69	$0.73	6.57%	BEAT
Q4 '24	$0.83	$0.91	8.98%	BEAT
Q3 '24	$0.82	$0.97	17.58%	BEAT

RUSHB
Rush Enterprises Inc - Ordinary Shares - Class B

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '25

Historical Earnings

Latest RUSHB News

RUSHB Rush Enterprises Inc - Ordinary Shares - Class B